ATE363075T1 - Verfahren zur diagnose und behandlung von metastasen und dafür nützliche zusammensetzung - Google Patents
Verfahren zur diagnose und behandlung von metastasen und dafür nützliche zusammensetzungInfo
- Publication number
- ATE363075T1 ATE363075T1 AT04017838T AT04017838T ATE363075T1 AT E363075 T1 ATE363075 T1 AT E363075T1 AT 04017838 T AT04017838 T AT 04017838T AT 04017838 T AT04017838 T AT 04017838T AT E363075 T1 ATE363075 T1 AT E363075T1
- Authority
- AT
- Austria
- Prior art keywords
- diagnosing
- useful composition
- composition therefor
- treating metastases
- smagp
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3076—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03016586 | 2003-07-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE363075T1 true ATE363075T1 (de) | 2007-06-15 |
Family
ID=34089578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04017838T ATE363075T1 (de) | 2003-07-28 | 2004-07-28 | Verfahren zur diagnose und behandlung von metastasen und dafür nützliche zusammensetzung |
Country Status (7)
Country | Link |
---|---|
US (1) | US20050032101A1 (de) |
JP (1) | JP4113167B2 (de) |
CN (2) | CN101649351A (de) |
AT (1) | ATE363075T1 (de) |
CA (1) | CA2469094A1 (de) |
DE (1) | DE602004006566T2 (de) |
ES (1) | ES2286539T3 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114933646A (zh) * | 2022-06-22 | 2022-08-23 | 南通市第一老年病医院(上海大学附属南通医院、南通市第六人民医院、南通市肺科医院) | Smagp蛋白多肽构建及其抗脂肪性肝病活性的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6974667B2 (en) * | 2000-06-14 | 2005-12-13 | Gene Logic, Inc. | Gene expression profiles in liver cancer |
US6448041B1 (en) * | 2000-12-18 | 2002-09-10 | Incyte Genomics, Inc. | Colon cancer marker |
-
2004
- 2004-06-28 CA CA002469094A patent/CA2469094A1/en not_active Abandoned
- 2004-07-21 US US10/895,865 patent/US20050032101A1/en not_active Abandoned
- 2004-07-28 CN CN200910164562A patent/CN101649351A/zh active Pending
- 2004-07-28 CN CNB200410058713XA patent/CN100541198C/zh not_active Expired - Fee Related
- 2004-07-28 JP JP2004220317A patent/JP4113167B2/ja active Active
- 2004-07-28 AT AT04017838T patent/ATE363075T1/de not_active IP Right Cessation
- 2004-07-28 DE DE602004006566T patent/DE602004006566T2/de active Active
- 2004-07-28 ES ES04017838T patent/ES2286539T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
CN100541198C (zh) | 2009-09-16 |
ES2286539T3 (es) | 2007-12-01 |
US20050032101A1 (en) | 2005-02-10 |
DE602004006566T2 (de) | 2008-01-24 |
CN101649351A (zh) | 2010-02-17 |
DE602004006566D1 (de) | 2007-07-05 |
CN1576840A (zh) | 2005-02-09 |
JP4113167B2 (ja) | 2008-07-09 |
CA2469094A1 (en) | 2005-01-28 |
JP2005130848A (ja) | 2005-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE516042T1 (de) | Zusammensetzungen und verfahren zur behandlung und diagnose von tumoren | |
ATE443260T1 (de) | Kontrastmittel und verfahren zum imaging von naaldase oder psma | |
ATE522623T1 (de) | Zusammensetzungen und verfahren zur behandlung und diagnose von lungentumoren | |
ATE493433T1 (de) | Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen | |
ATE353974T1 (de) | Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs | |
DE602004015064D1 (de) | Zusammensetzungen und verfahren zur diagnose und behandlung von kolonkrebs | |
ATE223727T1 (de) | Erkennung und modulierung von iaps und naip zur diagnose und behandlung von proliferativen erkrankungen | |
TW200626899A (en) | Frizzled proteins and detection and treatment of cancer | |
ATE453653T1 (de) | Platinkomplexe zur behandlung von tumoren | |
TW200626900A (en) | Wnt proteins and detection and treatment of cancer | |
DE602004016499D1 (de) | Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung | |
ATE368110T1 (de) | Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten | |
DE60126248D1 (de) | Verwendung von brustkrebs membranproteine für behandlung, prophylaxe und diagnose von brustkrebs | |
ATE480641T1 (de) | Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes | |
ATE338142T1 (de) | Methoden zur diagnose und behandlung von herzkrankheiten | |
ATE313561T1 (de) | Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen | |
ATE375389T1 (de) | Verfahren zur diagnose, prognose und behandlung von glaukom und verwandten erkrankungen | |
ATE363075T1 (de) | Verfahren zur diagnose und behandlung von metastasen und dafür nützliche zusammensetzung | |
DE60144493D1 (de) | Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen | |
EP1371729A3 (de) | Verwendungen von TFF3 bindenden Substanzen zur Diagnose und Behandlung von Krebserkrankungen | |
ATE414539T1 (de) | Verfahren und materialien zur behandlung und diagnose von mit kallikrein-6 zusammenhängenden entzündlichen zuständen | |
NO20075698L (no) | Preparater og fremgangsmater til diagnostisering og behandling av tumor | |
ATE390435T1 (de) | Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie | |
ATE397090T1 (de) | Verfahren und verbindungen zur diagnose von entzündlichen erkrankungen und identifizierung von pharmakologischen mitteln zur behandlung von entzündlichen erkrankungen | |
ATE546544T1 (de) | Verfahren zur diagnose und behandlung von lungenkrebs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |